Comprehensive Overview

The Group is a financial leasing company headquartered in Beijing. It engages in financial leasing and consulting services, mainly serving clients in the healthcare, aviation and public infrastructure industries in China.

According to the Insights Advisory Report, in 2017, the Group ranked 10th among foreign-funded medical device financing and leasing companies in China; in 2017, based on aircraft fleet size and aircraft financing and rental income, the Group was the third largest independent non-state-owned aircraft financing and leasing company in China.

According to the prospectus, it is assumed that the global sale was completed on August 31, 2018, and the net amount of tangible assets due to shareholders is not audited and adjusted to be between HK$0.94 and HK$1.23 per share.

Risk Factors

The Group's business is concentrated in the three major industries of healthcare, aviation and public infrastructure. The healthcare industry replaced the public infrastructure industry as the most important source of revenue in the 2017 fiscal year and the first 8 months of 2018. In fiscal year 2017 and the first 8 months of 2018, the revenue share from the healthcare industry accounted for approximately 51.9% and 70.6% of the Group's total revenue. Should the industry decline, unfavorable economic and market conditions, and major adverse changes in the regulatory environment occur, it may lead to a decline in the Group's demand for financing and leasing services, an increase in customer default agreements, and deterioration in the quality of rental assets, which in turn may have a significant adverse impact on the Group's operating performance.